岱勒新材(300700.SZ):上半年淨利預增107.88%-122.39%
格隆匯7月13日丨岱勒新材(300700.SZ)公佈2023年半年度業績預吿,報吿期歸屬於上市公司股東的淨利潤盈利8600萬元–9200萬元,比上年同期增長107.88%-122.39%;扣除非經常性損益後的淨利潤盈利8550萬元–9150萬元,比上年同期增長109.08%-123.75%。
報吿期內公司主要產品的產能較上年同期大幅提升,二季度整體生產滿產運行,產能得到穩定順利釋放,產銷量較上年同期大幅提升;雖然報吿期內公司主要產品價格略有下降,但是在產能規模效應、設備技術以及管理水平等各項措施不斷提升下,公司半年度業績仍取得了較好增長,盈利能力顯著提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.